Showing results (1571-1580 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|October 3, 2007
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancerAthanassios Argiris, Sanjiv S Agarwala, Michalis V Karamouzis, et al.
Investigational New Drugs|August 21, 2008
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancerElaina M Gartner, Kent A Griffith, Quintin Pan, et al.
Investigational New Drugs|October 9, 2007
The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitroMalin Wickström, Caroline Haglund, Henrik Lindman, et al.
Investigational New Drugs|July 5, 2008
Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecinS-J Lee, M Gounder, E H Rubin, et al.
Investigational New Drugs|September 28, 2007
The "old drug" dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomasPaolo Andrea Zucali, Alexia Bertuzzi, Hector Jose Soto Parra, et al.
Investigational New Drugs|November 18, 2008
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumorsSharon L Sanborn, Joseph Gibbons, Smitha Krishnamurthi, et al.
Investigational New Drugs|December 2, 2008
Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligandRaj K Koiri, Surendra K Trigun, Lallan Mishra, et al.
Investigational New Drugs|November 11, 2008
Blackberry-induced hand-foot skin reaction to sunitinibSusan L Boone, Gayle Jameson, Daniel Von Hoff, et al.
Investigational New Drugs|May 12, 2007
The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II studyCarlo Carnaghi, Armando Santoro, Lorenza Rimassa, et al.
Investigational New Drugs|July 14, 2007
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumorsJérôme Alexandre, Carmen Kahatt, Frédérique Bertheault-Cvitkovic, et al.
Pageof 372